Global Antibody Drug Conjugates( ADC) Market Analysis, Opportunities and Forecasts( 2017-2022)
Over the recent years, the Global Antibody Drug Conjugates Market has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.
Global Antibody Drug Conjugates( ADC) market is projected to display a robust growth represented by a CAGR of 21.82 % during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates. Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years.
Access Complete Report at http:// www. reportsnreports. com / reports / 927058-global-antibody-drug- conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and- forecasts-2017-2022-by-region-n-america-europe-apac-row-by-country-u-th-africa. html. Order this report by calling + 1 888 391 5441 or Send an email to sales @ reportsandreports. com with your contact details and questions if any.
© ReportsnReports. com / Contact sales @ reportsandreports. com
2